wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37588040-161A05D9-C69C-42EA-B540-66F68010B1F0
Q37588040-161A05D9-C69C-42EA-B540-66F68010B1F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37588040-161A05D9-C69C-42EA-B540-66F68010B1F0
Advances in antiangiogenic treatment of small-cell lung cancer.
P2860
Q37588040-161A05D9-C69C-42EA-B540-66F68010B1F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37588040-161A05D9-C69C-42EA-B540-66F68010B1F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ade145e2e5dcd8e82662f208fc1d0565c632878
P2860
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113.